3-hydroxyflavone has been researched along with Leucocythaemia in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, SG; Choi, HY; Kang, GH; Kim, JH; Kim, Y; Koo, BN; Lee, C; Lee, ER; Song, M | 1 |
Huo, X; Liu, K; Liu, W; Liu, Z; Ma, X; Meng, Q; Peng, J; Sun, H; Sun, P; Sun, Y; Wang, C; Yang, X | 1 |
Brouard, I; Estévez, F; Quintana, J; Said, M | 1 |
Akamatsu, N; Hasegawa, H; Hayashi, M; Ishibashi, M; Kam, TS; Kamihira, S; Komiyama, K; Koyano, T; Masuda, M; Murata, K; Sakai, T; Sugahara, K; Takasu, N; Tsukasaki, K; Tsuruda, K; Yamada, Y; Yoshida, T | 1 |
Enukidze, MG; Intskirveli, NA; Machavariani, MG; Mikautadze, MM; Sagareĭshvili, TG | 1 |
5 other study(ies) available for 3-hydroxyflavone and Leucocythaemia
Article | Year |
---|---|
Combined treatment of 3-hydroxyflavone and imatinib mesylate increases apoptotic cell death of imatinib mesylate-resistant leukemia cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Cell Death; Cell Survival; Cells, Cultured; Dogs; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Flavonoids; Humans; Imatinib Mesylate; K562 Cells; Leukemia; Piperazines; Pyrimidines | 2012 |
Combination of dihydromyricetin and ondansetron strengthens antiproliferative efficiency of adriamycin in K562/ADR through downregulation of SORCIN: A new strategy of inhibiting P-glycoprotein.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Calcium-Binding Proteins; Cell Proliferation; Down-Regulation; Doxorubicin; Drug Resistance, Neoplasm; Extracellular Signal-Regulated MAP Kinases; Flavonols; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; K562 Cells; Leukemia; Ondansetron; Proto-Oncogene Proteins c-akt; Signal Transduction | 2019 |
Antiproliferative activity and apoptosis induction by 3',4'-dibenzyloxyflavonol on human leukemia cells.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; BH3 Interacting Domain Death Agonist Protein; Caspase Inhibitors; Caspases; Cell Line, Tumor; Flavonols; Humans; Leukemia; Mitogen-Activated Protein Kinases; Phosphorylation; Reactive Oxygen Species; S Phase Cell Cycle Checkpoints | 2017 |
Dihydroflavonol BB-1, an extract of natural plant Blumea balsamifera, abrogates TRAIL resistance in leukemia cells.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Asteraceae; Drug Resistance, Neoplasm; Drug Synergism; Drug Therapy, Combination; Flavonols; Humans; Leukemia; Leukemia-Lymphoma, Adult T-Cell; Membrane Glycoproteins; Plant Extracts; Promoter Regions, Genetic; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; RNA, Small Interfering; Signal Transduction; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53 | 2006 |
[Pharmacological activity of dihydroflavonol glycoside isolated from the plant Eupatorium micranthum Less].
Topics: Antineoplastic Agents; Eupatorium; Flavonols; Glycosides; Humans; Leukemia; Neoplasms | 2008 |